Showing results (621-630 of 6,664) with videos related to

Sort By:
Pageof 667
Annals of Hematology|May 9, 2020
Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year periodEvangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Roussou, et al.
Annals of Hematology|May 9, 2020
Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trialsSomedeb Ball, Tapas Ranjan Behera, Faiz Anwer, et al.
Annals of Hematology|May 18, 2020
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real lifeClara Sortais, Anne Lok, Benoit Tessoulin, et al.
Annals of Hematology|May 18, 2020
Modern management of splenomegaly in patients with myelofibrosisDouglas Tremblay, Myron Schwartz, Richard Bakst, et al.
Annals of Hematology|May 11, 2020
Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progressJuanjuan Zhao, Meirong Wu, Zhifeng Li, et al.
Annals of Hematology|June 10, 2015
Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settingsJohanna Tischer, Nicole Engel, Susanne Fritsch, et al.
Annals of Hematology|June 9, 2015
Plasma microRNA-586 is a new biomarker for acute graft-versus-host diseaseYinuo Wang, Xiaosu Zhao, Xiaoyang Ye, et al.
Annals of Hematology|June 12, 2015
Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in MinnesotaAngela R Smith, Erica D Warlick, Michelle A Roesler, et al.
Annals of Hematology|July 1, 2015
Left ventricular remodeling in patients with sickle cell disease: determinants factors and impact on outcomeMaria Carmen M Vasconcelos, Maria Carmo P Nunes, Marcia M Barbosa, et al.
Annals of Hematology|July 5, 2015
A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantationIoanna Sakellari, Maria Angelopoulou, Olga Tsopra, et al.
Pageof 667